Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

701

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

701 results for “neoplasm”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov32/100

Epidemiological and Clinical-pathological Factors of Philadelphia-negative Myeloproliferative Neoplasms in Ecuador

ClinicalTrials.gov study NCT05825326. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms

ClinicalTrials.gov study NCT03808805. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Myeloproliferative Neoplasms and Bone Structure

ClinicalTrials.gov study NCT01816022. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad32/100

AID overexpression leads to aggressive murine CLL and non-Ig mutations that mirror human neoplasms

Open the record for dataset details and reuse information.

publicSep 2021View details →
dryad32/100

Targeted netrin inhibition disrupts DCC-dependent pathways and suppresses xenograft growth in neuroendocrine neoplasms

Open the record for dataset details and reuse information.

publicOct 2025View details →
dryad32/100

Characterizing the microbiome of patients with myeloproliferative neoplasms during a Mediterranean diet intervention

Open the record for dataset details and reuse information.

publicSep 2023View details →
zenodo28/100

Dataset Exner et al: mTOR inhibitor as radiosensitizers in neuroendocrine neoplasms

<p>Dataset Exner et al: mTOR inhibitor as radiosensitizers in neuroendocrine neoplasms</p>

opencc-by-4.0Jun 2020View details →
zenodo28/100

AGTR1 is overexpressed in neuroendocrine neoplasms, regulates secretion and may serve as a target for molecular imaging and therapy

<p>Numerical data for this manuscript.</p>

opencc-by-4.0Nov 2019View details →
zenodo28/100

Neoplasm topography and morphology corpus

<p>Pathology reports provide valuable information for cancer registries to understand, plan and implement strategies to mitigate the impact of cancer. However, coding key information from unstructured reports is done by experts in a time-consuming manual process. Here we report an automatic deep learning-based system that recognizes tumor morphology and topography mentions from free-text and suggests codes from the International Classification of Diseases for Oncology (ICD-O) in Spanish. This task was performed using the morphology guidelines and the Cantemist resource, an open corpus annotated with tumor morphology mentions created by the Barcelona Supercomputing Center, and the topography guidelines developed by us and inspired by the former. In this way we generated an annotated internal corpus of tumor morphology and topography mentions. Here, we applied transfer learning from state-of-the-art pre-trained language models to create a Named Entity Recognition (NER) model. The mentions found with this architecture are subsequently coded using a search engine tailored to the ICD-O codes. Our NER models achieved an F1-Score of 0.86 and 0.90 for tumor morphology and topography, respectively. The overall performance of our proposed automatic coding system achieved an accuracy at five suggestions of 0.72 and 0.65 for tumor morphology and topography, respectively. Our results demonstrate the feasibility of implementing NLP tools in the routine of a cancer center to extract and code valuable information from pathology reports.</p> <p>The tumor morphology corpus created in Spain, Cantemist corpus [<a href="https://doi.org/10.5281/zenodo.3773228">https://doi.org/10.5281/zenodo.3773228</a>], was developed at the Barcelona Supercomputing Center (funded by the &quot;Plan de Tecnolog&iacute;as del Language&quot;): &quot;Miranda-Escalada, A., Farr&eacute;, E., &amp; Krallinger, M. (2020). Named entity recognition, concept normalization and clinical coding: Overview of the cantemist track for cancer text mining in spanish, corpus, guidelines, methods and results. In Proceedings of the Iberian Languages Evaluation Forum (IberLEF 2020), CEUR Workshop Proceedings<br> &nbsp;</p> <p>This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. To view a copy of this license, visit&nbsp;<a href="http://creativecommons.org/licenses/by-nc-sa/4.0/">http://creativecommons.org/licenses/by-nc-sa/4.0/</a>.</p> <p>We are releasing the dataset in 2 formats:</p> <ul> <li>corpus_raw.zip: Contains the raw text files for each document along with its annotation file in Standoff format</li> <li>corpus.zip: Contains the corpus already tokenized and annotated using the IOB2 format. The corpus is separated into train, test and development subsets.</li> </ul>

openother-closedOct 2021View details →
zenodo28/100

Gastric Neuroendocrine Neoplasms based SEER data and external institutional hospital data

<p>The data including gastric neuroendocrine neoplasms based SEER data and external institutional hospital (First affiliated hospital of Soochow University)&nbsp;data&nbsp;aims to predict the predict the risk of lymph node metastasis among the gastric NENs patients based on the machine learning algorithms. Along with the paper titled Application of Machine Learning Algorithms to Predict Lymph Node Metastasis in Gastric Neuroendocrine Neoplasms, uploaded by author Lu Liu.</p>

opencc-by-4.0Feb 2023View details →
ClinicalTrials.gov28/100

Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms

ClinicalTrials.gov study NCT05553067. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

ClinicalTrials.gov study NCT00217425. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Retrospective Analysis of the Experience With Larotrectinib in Patients With Solid Neoplasms With NTRK Fusion in Spain (SPAINTRK)

ClinicalTrials.gov study NCT06837090. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

ClinicalTrials.gov study NCT07362225. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

ClinicalTrials.gov study NCT03878199. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.

ClinicalTrials.gov study NCT03869476. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients

ClinicalTrials.gov study NCT05842603. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms

ClinicalTrials.gov study NCT05787496. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

B7-H3.CD28Z.CART in CNS Neoplasms

ClinicalTrials.gov study NCT07390539. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms

ClinicalTrials.gov study NCT04830618. IPD Sharing: Not stated. Countries: 0. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.